DILIC
TEVA icon

Dai-ichi Life Insurance Company’s Teva Pharmaceuticals TEVA Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Buy
40,155
+300
+0.8% +$9.99K 0.03% 324
2026
Q1 		$1.2M Sell
39,855
-1,600
-4% -$51.5K 0.03% 323
2025
Q4 		$1.29M Sell
41,455
-186
-0.4% -$4.58K 0.03% 330
2025
Q3 		$841K Sell
41,641
-200
-0.5% -$3.51K 0.02% 393
2025
Q2 		$701K Buy
41,841
+11,797
+39% +$190K 0.02% 413
2025
Q1 		$462K Sell
30,044
-5,000
-14% -$89.3K 0.01% 451
2024
Q4 		$772K Sell
35,044
-2,200
-6% -$40K 0.02% 421
2024
Q3 		$671K Sell
37,244
-14,902
-29% -$261K 0.02% 442
2024
Q2 		$847K Buy
52,146
+2,697
+5% +$41.5K 0.02% 389
2024
Q1 		$698K Buy
49,449
+5,200
+12% +$65.5K 0.02% 403
2023
Q4 		$462K Hold
44,249
– – 0.01% 410
2023
Q3 		$451K Buy
44,249
+1,064
+2% +$9.91K 0.01% 420
2023
Q2 		$325K Hold
43,185
– – 0.01% 442
2023
Q1 		$382K Buy
43,185
+3,378
+8% +$33.4K 0.01% 437
2022
Q4 		$363K Buy
39,807
+4,807
+14% +$41.9K 0.01% 452
2022
Q3 		$282K Sell
35,000
-7,187
-17% -$63.6K 0.01% 455
2022
Q2 		$317K Hold
42,187
– – 0.01% 451
2022
Q1 		$396K Buy
42,187
+1,164
+3% +$9.71K 0.01% 468
2021
Q4 		$329K Sell
41,023
-7,391
-15% -$66.7K ﹤0.01% 482
2021
Q3 		$472K Hold
48,414
– – 0.01% 469
2021
Q2 		$479K Hold
48,414
– – 0.01% 472
2021
Q1 		$559K Hold
48,414
– – 0.01% 460
2020
Q4 		$467K Sell
48,414
-25,000
-34% -$240K 0.01% 446
2020
Q3 		$661K Sell
73,414
-1,013
-1% -$10.7K 0.01% 420
2020
Q2 		$918K Hold
74,427
– – 0.02% 386
2020
Q1 		$668K Sell
74,427
-20,000
-21% -$205K 0.03% 402
2019
Q4 		$925K Buy
94,427
+80,195
+563% +$716K 0.02% 420
2019
Q3 		$98K Hold
14,232
– – ﹤0.01% 518
2019
Q2 		$131K Sell
14,232
-20,765
-59% -$250K ﹤0.01% 533
2019
Q1 		$549K Hold
34,997
– – 0.01% 452
2018
Q4 		$540K Sell
34,997
-40,000
-53% -$820K 0.01% 422
2018
Q3 		$1.61M Hold
74,997
– – 0.04% 359
2018
Q2 		$1.82M Buy
74,997
+61,600
+460% +$1.26M 0.04% 326
2018
Q1 		$229K Hold
13,397
– – ﹤0.01% 484
2017
Q4 		$254K Hold
13,397
– – ﹤0.01% 470
2017
Q3 		$236K Hold
13,397
– – 0.01% 482
2017
Q2 		$445K Sell
13,397
-4,429
-25% -$137K 0.01% 436
2017
Q1 		$572K Sell
17,826
-39,254
-69% -$1.34M 0.02% 430
2016
Q4 		$2.07M Buy
+57,080
New +$2.28M 0.06% 294

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Dai-ichi Life Insurance Company's TEVA Position: Q2 2026 in Review

Dai-ichi Life Insurance Company increased its Teva Pharmaceuticals (TEVA) stake by 0.75% in Q2 2026, buying an estimated $9.99K and bringing the position to 40,155 shares worth $1.36M. The position accounts for 0.03% of the portfolio, ranked #324.

Dai-ichi Life Insurance Company first reported a position in TEVA in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.07M in Q4 2016. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Dai-ichi Life Insurance Company held 40,155 shares of Teva Pharmaceuticals worth $1.36M as of Q2 2026.
  • Dai-ichi Life Insurance Company bought 300 Teva Pharmaceuticals shares in Q2 2026, an estimated $9.99K.
  • Teva Pharmaceuticals made up 0.03% of Dai-ichi Life Insurance Company's portfolio in Q2 2026, its #324 holding.
  • Dai-ichi Life Insurance Company first reported a position in Teva Pharmaceuticals in Q4 2016 and has held it in 39 quarters since.
  • Dai-ichi Life Insurance Company's Teva Pharmaceuticals position peaked at $2.07M in Q4 2016.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2026, filed 12 Aug 2026.